NCT04642339: Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela
- State
- State not given
- Phase
- Phase 3
- People
- 2,000 planned
- Started
- Nov 2020
- Primary completion
- Oct 2021
- Arms
- Vaccine Gam-COVID-Vac
- Results
- None posted
- 24 Nov 2020: Trial registered